FIELD: medicine.
SUBSTANCE: to correct pathologic changes in the condition of viable offspring under a cytostatic impact the medication glutoxim is introduced to female rats in a dose of 50 mcg/kg 5 days before and 5 days after the introduction of the cytostatic medication vepesid. The latter is introduced once intravenously in a maximal tolerable dose, equal to 30 mg/kg. It has been established that glutoxim can be applied as means for the correction of pathologic changes in the viable offspring of rats, obtained from coupling 3 months after the cytostatic impact.
EFFECT: application of glutoxim as the means of corrective therapy makes it possible to increase efficiency and reduce its side effects.
6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR CORRECTION OF FEMALE REPRODUCTIVE DYSFUNCTION CAUSED BY CYTOSTATIC EXPOSURE | 2008 |
|
RU2367420C1 |
| CORRECTOR FOR DISORDERS OF FEMALE REPRODUCTIVE FUNCTION CAUSED BY CYTOSTATIC PREPARATIONS | 2003 |
|
RU2253468C2 |
| MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
| METHOD OF CORRECTING, CAUSED BY CYTOSTATIC IMPACT | 2009 |
|
RU2406527C1 |
| MEANS FOR PREVENTING AND CORRECTING SPERMATOGENESIS DISORDERS CAUSED BY CYTOSTATIC TREATMENT | 2006 |
|
RU2318529C1 |
| METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
| METHOD FOR PREVENTION AND CORRECTION OF CYTOGENETIC DISORDER | 2012 |
|
RU2504392C1 |
| METHOD FOR TREATING AFFECTED AMNESTIC FUNCTIONS | 2004 |
|
RU2268726C2 |
| AGENT FOR PREVENTING AND TREATING ASTHENOZOOSPERMIA AND TERATOZOOSPERMIA | 2020 |
|
RU2739491C1 |
| SUBSTANCE ENHANCING SEXUAL ACTIVITY, CONCEPTION EFFECTIVENESS AND ELIMINATING ERECTILE DYSFUNCTION | 2001 |
|
RU2206323C2 |
